The trend / Deal note
Yellow Wood / Nestlé
Four weeks after P&G paid 5.8x, a seller put the other half of the same aisle on the market at 0.8x. That is the moment the pattern stopped being a coincidence.
| Buyer | Yellow Wood Partners |
|---|---|
| Seller | Nestlé |
| Consideration | $1.0bn |
| Portfolio sales, 2025 | $1.2bn |
| Implied multiple | ~0.8x trailing sales |
| Brands | Nature’s Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan’s Pride, Sisu |
| Also included | US private label, plants, distribution |
| Nestlé retains | Solgar, Pure Encapsulations |
| Expected close | First half of 2027 |
The detail that gives it away
Read the retained list. Nestlé kept Solgar and Pure Encapsulations, its two premium science-led brands, and sold the seven that compete on price and placement. Its CEO said the company is focusing where it has the strongest competitive advantage, which is the politest possible way of saying these two things are not the same business.
Eight weeks earlier the market had priced trust at 5.8x. Here is a seller applying the identical split to its own portfolio, with real money, in public.
What below 1x actually buys
At 0.8x sales you are not buying brands that compound. You are buying cash flow, a manufacturing base, and a distribution network, and the return has to come from operating the assets better than a conglomerate bothered to. Yellow Wood is a consumer carve-out specialist. This is a carve-out, not a growth story, and the price is honest about that.
They have flagged hydration, gut health and immunity as the pockets with room. That reads right to me, and it points at one brand in particular.
The one I would watch
Nuun. Hydration is the only line in this portfolio that behaves like it belongs on the other side of the Venn. If it keeps growing, Yellow Wood bought a growth asset inside a value basket and paid value prices for it, which is how carve-outs make their reputation.
- Standing up services the parent used to provide is where carve-outs usually slip.
- Owned brands plus private label under one roof is a channel conflict, not a synergy.
- Below 1x there is no multiple to hide behind. It is all operating execution.
My call
The right price for what it is, and the most useful deal on the list, because it is the one that proves the framework. P&G told you what trust costs. Nestlé told you what everything else costs.
Sources
- NutraIngredients, terms, brands and portfolio sales.
- Nutritional Outlook, scope and retained brands.
If you have a better read on this one, I would like to hear it. fyruan@usc.edu